hydrochlorothiazide has been researched along with Coronary Disease in 60 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to investigate the influences of Simvastatin (Zocor) on nitric oxide (NO), calcitonin gene related peptide (CGRP) and endothelin (ET) in blood plasma of patients with coronary heart disease (CHD) complicated with congestive heart failure (CHF)." | 9.17 | Influences of simvastatin on vascular endothelial function of patients with coronary heart disease complicated with congestive heart failure. ( Shi, J; Wang, L; Zhang, Y, 2013) |
| "In 78 patients with mild or moderate hypertension, effect of acebutolol and hydrochlorothiazide on plasma lipids, lipoproteins, fibrinogen and plasma fibrinolysis time were investigated." | 7.68 | [Does chronic therapy of hypertension with acebutolol or hydrochlorothiazide effect coronary risk factors?]. ( Karolko, B; Kopel, E; Kübler, G; Witkowska, M, 1991) |
| "In 59 patients with mild or moderate essential hypertension effects of propranolol and hydrochlorothiazide on serum lipids, fibrynogen, glucose and uric acid concentrations as well as serum euglobulins fibrynolysis time were studied." | 7.67 | [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension]. ( Karolko, B; Kawecka, M; Lukasik, S; Moszczyńska, J; Witkowska, M, 1989) |
| "The impact of treating hypertension on coronary artery disease has been less than anticipated from epidemiologic studies of cardiovascular risk factors." | 6.67 | Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group. ( Carruthers, G; Dessain, P; Fodor, G; Newman, C; Palmer, W; Sim, D, 1993) |
| "The aim of this study was to investigate the influences of Simvastatin (Zocor) on nitric oxide (NO), calcitonin gene related peptide (CGRP) and endothelin (ET) in blood plasma of patients with coronary heart disease (CHD) complicated with congestive heart failure (CHF)." | 5.17 | Influences of simvastatin on vascular endothelial function of patients with coronary heart disease complicated with congestive heart failure. ( Shi, J; Wang, L; Zhang, Y, 2013) |
| "The ACCOMPLISH (Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension) trial compared the outcomes effects of a renin-angiotensin system blocker, benazepril, combined with amlodipine (B+A) or hydrochlorothiazide (B+H)." | 5.14 | Cardiovascular events during differing hypertension therapies in patients with diabetes. ( Bakris, GL; Dahlöf, B; Devereux, RB; Hester, A; Hua, TA; Jamerson, K; Kelly, RY; Kjeldsen, SE; Pitt, B; Velazquez, EJ; Weber, MA; Weir, M, 2010) |
| "To understand the effects of single- and multiple-drug combinations for hypertension on the risk of adverse clinical outcomes, the authors analyzed data from the International Verapamil SR/Trandolapril Study (INVEST)." | 3.73 | A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients. ( Cooper-DeHoff, R; Elliott, WJ; Hewkin, AC; Kupfer, S; Pepine, CJ, 2005) |
| "To assess whether therapy with hydrochlorothiazide (HCTZ) or the calcium antagonist nitrendipine influences silent ischemia or arrhythmias, we studied 10 asymptomatic hypertensive male patients with positive Tl-201 scintigraphy in a double-blind, crossover protocol." | 3.68 | Influence of therapy on silent ischemia and ventricular arrhythmias in hypertensive patients. ( Ammon, S; Massie, BM; O'Kelly, B; Szlachcic, J; Tubau, JF, 1991) |
| "In 78 patients with mild or moderate hypertension, effect of acebutolol and hydrochlorothiazide on plasma lipids, lipoproteins, fibrinogen and plasma fibrinolysis time were investigated." | 3.68 | [Does chronic therapy of hypertension with acebutolol or hydrochlorothiazide effect coronary risk factors?]. ( Karolko, B; Kopel, E; Kübler, G; Witkowska, M, 1991) |
| "In 59 patients with mild or moderate essential hypertension effects of propranolol and hydrochlorothiazide on serum lipids, fibrynogen, glucose and uric acid concentrations as well as serum euglobulins fibrynolysis time were studied." | 3.67 | [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension]. ( Karolko, B; Kawecka, M; Lukasik, S; Moszczyńska, J; Witkowska, M, 1989) |
| "Patients with high blood pressure are often overweight or even obese." | 2.71 | [Arterial hypertension in obese patients. Rationale for a prospective medical care study in the family doctor's practice]. ( Bramlage, P; Kirch, W; Sharma, AM, 2004) |
| "The impact of treating hypertension on coronary artery disease has been less than anticipated from epidemiologic studies of cardiovascular risk factors." | 2.67 | Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group. ( Carruthers, G; Dessain, P; Fodor, G; Newman, C; Palmer, W; Sim, D, 1993) |
| "More metoprolol-treated patients withdrew because of depression (6 vs less than 1%; p = 0." | 2.66 | Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol. ( Ahmad, S; Glasser, SP; Lucas, C; Lutz, LJ; Materson, BJ; Morledge, JH; Ramanathan, KB; Saunders, E; Schnaper, HW; Vlachakis, ND, 1989) |
| "Hydrochlorothiazide was used alone in 36 percent of patients, in combination with propranolol in 26 percent, and with methyldopa in 20 percent." | 2.66 | Coronary heart disease and treatment of hypertension. Some Oslo Study data. ( Helgeland, A; Leren, P, 1986) |
| "Hyperlipidemia is a widely acknowledged side effect of thiazide diuretic therapy, but it is often dismissed as a short-term effect of high-dose therapy." | 2.40 | Hyperlipidemia of diuretic therapy. ( Ames, R, 1998) |
| "The treatment of both hyperlipidemia and hypertension appeared to be more effective than the treatment of hyperlipidemia, alone." | 1.26 | Aggravation of atherosclerosis by hypertension in a subhuman primate model with coarctation of the aorta. ( Hollander, W; Kirkpatrick, B; Madoff, I; Paddock, J, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (73.33) | 18.7374 |
| 1990's | 8 (13.33) | 18.2507 |
| 2000's | 6 (10.00) | 29.6817 |
| 2010's | 2 (3.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L | 1 |
| Shi, J | 1 |
| Zhang, Y | 1 |
| Krikken, JA | 1 |
| Waanders, F | 1 |
| Dallinga-Thie, GM | 1 |
| Dikkeschei, LD | 1 |
| Vogt, L | 1 |
| Navis, GJ | 1 |
| Dullaart, RP | 1 |
| Weingärtner, O | 1 |
| Böhm, M | 1 |
| Laufs, U | 1 |
| Weber, MA | 1 |
| Bakris, GL | 1 |
| Jamerson, K | 1 |
| Weir, M | 1 |
| Kjeldsen, SE | 1 |
| Devereux, RB | 1 |
| Velazquez, EJ | 1 |
| Dahlöf, B | 1 |
| Kelly, RY | 1 |
| Hua, TA | 1 |
| Hester, A | 1 |
| Pitt, B | 1 |
| Reese, AM | 1 |
| Talbert, RL | 1 |
| Bussey, HI | 1 |
| SCHWARTZ, G | 1 |
| STECHEL, GH | 1 |
| FISHMAN, SI | 1 |
| FANKHAUSER, A | 1 |
| BUZZI, RM | 1 |
| SAMMARTINO, F | 1 |
| MAS, FR | 1 |
| LA ROSA, C | 1 |
| SANCHETTI, P | 1 |
| FAVERO, S | 1 |
| OZDOGAN, E | 1 |
| SCHWARTZ, W | 1 |
| COHEN, MH | 1 |
| ROSEN, RJ | 1 |
| SETTEL, E | 1 |
| Rollins, G | 1 |
| Elliott, WJ | 1 |
| Hewkin, AC | 1 |
| Kupfer, S | 1 |
| Cooper-DeHoff, R | 1 |
| Pepine, CJ | 1 |
| Bramlage, P | 1 |
| Sharma, AM | 1 |
| Kirch, W | 1 |
| Cressman, MD | 1 |
| Gifford, RW | 1 |
| Schmieder, R | 2 |
| Friedrich, G | 2 |
| Neus, H | 2 |
| Rüdel, H | 1 |
| von Eiff, AW | 2 |
| Strec, V | 1 |
| Brdová, L | 1 |
| Petrovicová, J | 1 |
| Brugger, P | 1 |
| Klein, G | 1 |
| Helgeland, A | 3 |
| Angelkort, B | 1 |
| Letzel, H | 1 |
| Rüddel, H | 1 |
| Morgan, DB | 1 |
| Davidson, C | 1 |
| Carruthers, G | 1 |
| Dessain, P | 1 |
| Fodor, G | 1 |
| Newman, C | 1 |
| Palmer, W | 1 |
| Sim, D | 1 |
| Zanchetti, A | 1 |
| Ames, R | 1 |
| Byington, RP | 1 |
| Furberg, CD | 2 |
| Craven, TE | 1 |
| Pahor, M | 1 |
| Sowers, JR | 1 |
| de Pasquale, C | 1 |
| Currò, F | 1 |
| Amadeo, A | 1 |
| Hollander, W | 1 |
| Madoff, I | 1 |
| Paddock, J | 1 |
| Kirkpatrick, B | 1 |
| Cohen, JD | 2 |
| Szlachcic, J | 1 |
| Tubau, JF | 1 |
| O'Kelly, B | 1 |
| Ammon, S | 1 |
| Massie, BM | 1 |
| Witkowska, M | 2 |
| Kübler, G | 1 |
| Kopel, E | 1 |
| Karolko, B | 2 |
| Kuller, LH | 1 |
| Hulley, SB | 1 |
| Neaton, J | 1 |
| Materson, BJ | 1 |
| Vlachakis, ND | 1 |
| Glasser, SP | 1 |
| Lucas, C | 1 |
| Ramanathan, KB | 1 |
| Ahmad, S | 1 |
| Morledge, JH | 1 |
| Saunders, E | 1 |
| Lutz, LJ | 1 |
| Schnaper, HW | 1 |
| Lukasik, S | 1 |
| Kawecka, M | 1 |
| Moszczyńska, J | 1 |
| Rockhold, FW | 1 |
| Goldberg, MR | 1 |
| Thompson, WL | 1 |
| Leren, P | 2 |
| Kaplan, NM | 1 |
| Löllgen, H | 1 |
| Schmidt, A | 1 |
| Upmeyer, HJ | 1 |
| Samuelsson, O | 1 |
| Berglund, G | 1 |
| Elmfeldt, D | 1 |
| Wilhelmsen, L | 1 |
| Wikstrand, J | 1 |
| Houston, MC | 1 |
| Johnston, PE | 1 |
| Cutler, JA | 1 |
| Schiffl, H | 1 |
| Schollmeyer, P | 1 |
| Kuller, L | 1 |
| Farrier, N | 1 |
| Caggiula, A | 1 |
| Borhani, N | 1 |
| Dunkle, S | 1 |
| Ryvkin, IA | 1 |
| Korsunskiĭ, AA | 1 |
| Pribylova, LP | 1 |
| Lobanova, LS | 1 |
| Raĭskaia, AM | 1 |
| Teichmann, G | 1 |
| Löper, W | 1 |
| Freis, ED | 1 |
| Chasis, H | 1 |
| Laidlaw, JC | 1 |
| Sidorenko, BA | 1 |
| Kharchenko, VI | 1 |
| Titov, VN | 1 |
| Lotova, EV | 1 |
| Mel'nichenko, GA | 1 |
| Smolenskiĭ, VS | 1 |
| Mazel', GS | 1 |
| Pisano, G | 1 |
| Ghia, G | 1 |
| Yasui, H | 1 |
| Ira, TS | 1 |
| Zinner, EN | 1 |
| Tretenhahn, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients With High Risk Hypertension[NCT00170950] | Phase 3 | 11,506 participants (Actual) | Interventional | 2003-10-31 | Terminated (stopped due to The study was terminated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.) | ||
| INternational VErapamil SR Trandolapril STudy[NCT00133692] | Phase 4 | 22,000 participants | Interventional | 1997-09-30 | Completed | ||
| [NCT00000487] | Phase 3 | 0 participants | Interventional | 1972-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
CV mortality was defined as death due to sudden cardiac death, fatal MI, fatal stroke, coronary intervention, congestive heart failure (CHF), or other CV causes. (NCT00170950)
Timeframe: For each patient, baseline to time of first CV mortality event, MI (non-fatal), or stroke (non-fatal) (or last exposure if no event occurred). (Median duration of exposure was 33.4 months. [25th to 75th percentiles: 21 to 41 months.])
| Intervention | Percentage of Patients with an Event (Number) |
|---|---|
| Benazepril/Amlodipine | 5.0 |
| Benazepril/Hydrochlorothiazide | 6.3 |
Cardiovascular morbidity was defined as including any of the following events: non-fatal MI, non-fatal stroke, hospitalization for unstable angina, resuscitated sudden death, or coronary revascularization procedure (PCI or CABG). (NCT00170950)
Timeframe: For each patient, baseline to time of first CV morbidity event (or last exposure if no event occurred). (Median duration of exposure was 33.4 months. [25th to 75th percentiles: 21 to 41 months.])]
| Intervention | Percentage of Patients with an Event (Number) |
|---|---|
| Benazepril/Amlodipine | 8.6 |
| Benazepril/Hydrochlorothiazide | 10.3 |
CV morbidity was defined as non-fatal myocardial infarction (MI), non-fatal stroke, hospitalization for unstable angina, resuscitated sudden death, or coronary revascularization procedure. CV mortality was defined as death due to MI, stroke, coronary intervention, congestive heart failure (CHF), sudden cardiac death, or other CV causes. (NCT00170950)
Timeframe: For each patient, baseline to time of first CV morbidity or mortality event (or last exposure if no event occurred). (Median duration of exposure was 33.4 months. [25th to 75th percentiles: 21 to 41 months.])
| Intervention | Percentage of Patients with an event (Number) |
|---|---|
| Benazepril/Amlodipine | 9.6 |
| Benazepril/Hydrochlorothiazide | 11.8 |
6 reviews available for hydrochlorothiazide and Coronary Disease
| Article | Year |
|---|---|
[Exertion hypertension in coronary disease and its importance in prevention and rehabilitation].
Topics: Adult; Coronary Disease; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle | 1982 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive | 1997 |
Hyperlipidemia of diuretic therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cere | 1998 |
[Importance of the continuity of anti-hypertension treatment in prevention of ischemic cardiovascular diseases: preliminary note. Controlled study of hypertensive patients treated with amiloride associated with hydrochlorothiazide and chlorthalidone].
Topics: Adult; Aged; Amiloride; Chlorthalidone; Coronary Disease; Drug Therapy, Combination; Female; Humans; | 1978 |
Essential hypertension: new insights and controversies in treatment with diuretics.
Topics: Amiloride; Antihypertensive Agents; Blood Pressure; Coronary Disease; Diuretics; Dose-Response Relat | 1986 |
Effectiveness of drug therapy in hypertension: present status. A review.
Topics: Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Eye Diseases; Ganglionic Block | 1971 |
24 trials available for hydrochlorothiazide and Coronary Disease
| Article | Year |
|---|---|
Influences of simvastatin on vascular endothelial function of patients with coronary heart disease complicated with congestive heart failure.
Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Coronary Disease; Digoxin; Drug Therapy, Combination; | 2013 |
Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin.
Topics: Adiponectin; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Cholesterol Ester Transfer Protei | 2009 |
Cardiovascular events during differing hypertension therapies in patients with diabetes.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; B | 2010 |
[Arterial hypertension in obese patients. Rationale for a prospective medical care study in the family doctor's practice].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; C | 2004 |
Controversies in hypertension: mild hypertension, isolated systolic hypertension, and the choice of a step one drug.
Topics: Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; | 1983 |
The influence of beta blockers on cardiovascular reactivity and Type A behavior pattern in hypertensives.
Topics: Amiloride; Atenolol; Blood Pressure; Coronary Disease; Drug Therapy, Combination; Heart Rate; Humans | 1983 |
Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.
Topics: Adult; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Drug T | 1980 |
[Clinical aspects and therapy of hydropic heart insufficiency. Results of a multicenter field study].
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Edema, Cardiac; | 1981 |
Effects of beta-blockers on type-A coronary-prone behaviour.
Topics: Amiloride; Atenolol; Blood Pressure; Coronary Disease; Humans; Hydrochlorothiazide; Hypertension; Ma | 1982 |
Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
Topics: Adult; Aged; Atenolol; Cholesterol; Cholesterol, HDL; Coronary Disease; Double-Blind Method; Doxazos | 1993 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive | 1997 |
Isradipine in prediabetic hypertensive subjects.
Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Dis | 1998 |
Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
Topics: Aged; Amiloride; Atenolol; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Diu | 1992 |
Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Cholesterol; Coronary Disease; Double-B | 1989 |
Beneficial effects of pinacidil on blood lipids: comparisons with prazosin and placebo in patients with hypertension. Pinacidil-Prazosin and Pinacidil-Placebo Research Groups, Lilly Research Laboratories.
Topics: Antihypertensive Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; | 1989 |
Coronary heart disease and treatment of hypertension. Some Oslo Study data.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Glucose; Carbohydrate | 1986 |
Oslo Hypertension Study.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Cholesterol, HDL; Coronary Disease; Follow-Up Stu | 1986 |
[Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Aged; Amiloride; Clinical Trials as Topic; Coronary Disease; Double-Bli | 1986 |
QRS-amplitudes during antihypertensive treatment: a comparison between beta-blocker and thiazide diuretic regimens.
Topics: Adult; Aged; Blood Pressure; Cardiomegaly; Clinical Trials as Topic; Coronary Disease; Electrocardio | 1986 |
Drug treatment trials in hypertension: a review.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Coro | 1985 |
Metabolic consequences of long-term thiazide-based antihypertensive treatment of renal hypertension.
Topics: Adolescent; Adult; Aged; Amiloride; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Dr | 1985 |
Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.
Topics: Adult; Age Factors; Aged; Aneurysm; Atrial Fibrillation; Blood Glucose; Blood Pressure; Cerebrovascu | 1972 |
Appraisal of antihypertensive drug therapy.
Topics: Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Diabetes Comp | 1974 |
Hypertension: a challenge in preventive medicine.
Topics: Age Factors; Attitude to Health; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disea | 1974 |
31 other studies available for hydrochlorothiazide and Coronary Disease
| Article | Year |
|---|---|
[67-year-old patient with abdominal pain and pronounced peritonitis].
Topics: Abdominal Pain; Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; | 2009 |
Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chlorthalidone; Coronary Disease; | 2003 |
Clinical therapeutic evaluation of hydrochlorothiazide (hydrodiuril).
Topics: Acetazolamide; Coronary Disease; Diuretics; Heart Diseases; Humans; Hydrochlorothiazide; Hypertensio | 1959 |
[Hydrochlorothiazide in clinical practice].
Topics: Chlorothiazide; Coronary Disease; Diuretics; Hydrochlorothiazide; Hypertension; Kidney Diseases; Liv | 1960 |
[CLINICAL STUDY OF A NEW COMPLEX HYPOTENSIVE DRUG COMBINATION].
Topics: Antihypertensive Agents; Arteriosclerosis; Carbamates; Cerebrovascular Disorders; Coronary Disease; | 1963 |
[ON ION TRANSPORT BEFORE AND AFTER TREATMENT OF CONGESTIVE HEART FAILURE].
Topics: Chlorthalidone; Coronary Disease; Digitalis Glycosides; Diuretics; Electrolytes; Heart Failure; Huma | 1963 |
MEBUTAMATE AND HYDROCHLOROTHIAZIDE IN HYPERTENSION.
Topics: Antihypertensive Agents; Arthritis; Arthritis, Rheumatoid; Blood Pressure Determination; Carbamates; | 1964 |
PROLONGED CARDIOGENIC SHOCK WITH RECOVERY.
Topics: Angina Pectoris; Coronary Disease; Digoxin; Electrocardiography; Hydrochlorothiazide; Hypercholester | 1964 |
SMALL-BOWEL ULCERS WITH THAIZIDE AND POTASSIUM.
Topics: Coronary Disease; Diuretics; Hydrochlorothiazide; Hypertension; Ileum; Intestinal Diseases; Potassiu | 1965 |
FURTHER EXPERIENCE WITH SPIRONOLACTONE-HYDRO-CHLOROTHIAZIDE (ALDACTAZIDE-A) IN THE LONG-TERM TREATMENT OF REFRACTORY CARDIAC EDEMA.
Topics: Arteriosclerosis; Chlorothiazide; Coronary Disease; Drug Combinations; Drug Therapy; Edema; Edema, C | 1965 |
Calcium antagonist and beta blocker regimens found equally effective in hypertensive patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Coronary Disease; Di | 2004 |
A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients.
Topics: Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chi-Square Distribution; Coronary Disea | 2005 |
[Effective pharmacotherapy with diuretics in spa therapy].
Topics: Adult; Balneology; Coronary Disease; Diuresis; Humans; Hydrochlorothiazide; Male; Middle Aged; Risk | 1983 |
Hypokalaemia and diuretics: an analysis of publications.
Topics: Chlorothiazide; Chlorthalidone; Coronary Disease; Diuretics; Dose-Response Relationship, Drug; Furos | 1980 |
Aggravation of atherosclerosis by hypertension in a subhuman primate model with coarctation of the aorta.
Topics: Animals; Aortic Coarctation; Arteriosclerosis; Blood Pressure; Body Weight; Cholesterol, Dietary; Co | 1976 |
Abnormal electrocardiograms and cardiovascular risk: role of silent myocardial ischemia. Evidence from MRFIT.
Topics: Adult; Antihypertensive Agents; Chlorthalidone; Cholesterol, Dietary; Coronary Disease; Electrocardi | 1992 |
Influence of therapy on silent ischemia and ventricular arrhythmias in hypertensive patients.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Electrocardiography, Ambulatory | 1991 |
[Does chronic therapy of hypertension with acebutolol or hydrochlorothiazide effect coronary risk factors?].
Topics: Acebutolol; Adult; Coronary Disease; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male | 1991 |
Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis.
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomegaly; Catecholamines; Chlorthalid | 1986 |
[Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension].
Topics: Adult; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Hydrochlorothiazide; Hype | 1989 |
Problems with the use of diuretics in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Coronary Disease; Diuretics; Female; Humans; Hydrochlor | 1986 |
Relationship of diuretic therapy and serum magnesium levels among participants in the Multiple Risk Factor Intervention Trial.
Topics: Adult; Blood Pressure; California; Chlorthalidone; Coronary Disease; Diet; Epidemiologic Methods; Hu | 1985 |
Results of treatment of hypertension.
Topics: Acute Kidney Injury; Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Female; Hum | 1971 |
[Initial results of the activity of the Angiocardiological Center in Kolomna].
Topics: Adolescent; Adult; Coronary Disease; Diabetes Complications; Female; Heparin; Humans; Hydrochlorothi | 1971 |
[Use, association and contraindications of hypotensive drugs].
Topics: Antihypertensive Agents; Blood Pressure; Coronary Disease; Diuretics; Furosemide; Ganglionic Blocker | 1969 |
[Comparison of the effectiveness and mechanism of action of the saluretic preparations triamterene and hypothiazide and their combination (triampur) in circulatory insufficiency].
Topics: Acid-Base Equilibrium; Adult; Aged; Arteriosclerosis; Circadian Rhythm; Coronary Disease; Creatinine | 1973 |
[Origin and treatment of arterial hypertension in middle and old age].
Topics: Aged; Benzimidazoles; Coronary Disease; Humans; Hydrochlorothiazide; Hypertension; Intracranial Arte | 1972 |
[Clinical observations on the diuretic action of the association of triamterene with hydrochlorothiazide].
Topics: Adult; Aged; Coronary Disease; Diuresis; Edema; Heart Diseases; Heart Failure; Humans; Hydrochloroth | 1967 |
The role of catecholamines in circulatory regulation on the chronic congestive heart failure. Clinical study of the urinary catecholamine excretion in the patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiomyopathies; Catecholamines; Coronary Disease; Digital | 1968 |
Small bowel ulceration.
Topics: Aged; Coronary Disease; Diagnosis, Differential; Female; Humans; Hydrochlorothiazide; Ileum; Intesti | 1966 |
[The treatment of hypertension].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Child; Child, Preschool; Coronar | 1966 |